Monica Otto

Government, Health and Not for Profit

Biografia

Pubblicazioni recenti

ARMENI P., CALLEA G., COSTA F., MALANDRINI F., OTTO M., SEGANTIN G., SIRENA P., TARRICONE R. Il payback come misura di contenimento della spesa per farmaci e dispositivi medici in Rapporto OASI 2023 CERGAS (a cura di), Egea, chap. 17, pp.651-698, 2023
ARMENI P., COSTA F., JOMMI C., MALANDRINI F., OTTO M., TARANTOLA A. L’evoluzione del finanziamento dei farmaci in Italia in Rapporto OASI 2023 CERGAS (a cura di), Egea, chap. 8, pp.317-354, 2023
TARANTOLA A., OTTO M., ARMENI P., Costa F., MALANDRINI F., JOMMI C. Early access programs for medicines: comparative analysis among France, Italy, Spain, and UK and focus on the Italian case Journal of Pharmaceutical Policy and Practice, 2023, vol.16, no. 1
JOMMI C., BERTOLANI A., ARMENI P., COSTA F., OTTO M. Pharmaceutical pricing and managed entry agreements: an exploratory study on future perspectives in Europe Health Policy and Technology, 2023, pp.100771
FERRARA L., OTTO M., Aapro M., Albreht T., Jonsson B., Oberst S., Oliver K., Pisani E., Presti P., Rubio I. T., Terkola R., TARRICONE R. How to improve efficiency in cancer care: Dimensions, methods, and areas of evaluation Journal of Cancer Policy, 2022, vol.34, pp.100355
JOMMI C., ARMENI P., BERTOLANI A., COSTA F., OTTO M. The future of Funds for Innovative Medicines: results from a Delphi Study Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish, 2021, vol.8, pp.22-28

Articoli correlati

Hospital Management during pandemic crisis: Lessons Learn...
Autori
Tempo richiesto 1 ora